Flutter Over Biocon’s Repurposed Psoriasis Drug For COVID-19 In India
Emergency Use But Some Concern Over Small Trial
Biocon’s itolizumab gets clearance in India for restricted emergency use in COVID-19 patients, amid some concerns around small study numbers. But company says data are compelling and cites compassionate use substantiation, while partner Equillium expects to pursue a global study under US IND.
